Back to discover
Disease

Hyperhomocysteinemia

Late-stage therapeutic developmentEmerging research
2
Publications
8
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

6 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
8
All trials
0
Active
3
Late-stage
5
Completed
Recently completed

Research activity

2 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20062024
Most influential
Recent publications
Major themes3
  • Homocysteine1
  • Parkinson Disease1
  • Protein Deglycase DJ-11
Leading journals2
  • Aging cell1
  • The New England journal of medicine1
Leading researchers8
  • Arnold MJ1
  • Bao A1
  • Chen G1
  • Fodor G1
  • Genest J Jr1
  • Guo T1
  • Held C1
  • Hu D1
Affiliations (unnormalised)5
  • Department of Clinical Laboratory1
  • Population Health Research Institute1
  • Renmin Hospital of Wuhan University1
  • Second Affiliated Hospital of Nanchang University1
  • TaiKang Center for Life and Medical Sciences1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Condition in which the plasma levels of homocysteine and related metabolites are elevated (>13.9 μmol/l). Hyperhomocysteinemia can be familial or acquired. Development of the acquired hyperhomocysteinemia is mostly associated with vitamins B and/or folate deficiency (e.g., PERNICIOUS ANEMIA, vitamin malabsorption). Familial hyperhomocysteinemia often results in a more severe elevation of total homocysteine and excretion into the urine, resulting in HOMOCYSTINURIA. Hyperhomocysteinemia is a risk factor for cardiovascular and neurodegenerative diseases, osteoporotic fractures and complications during pregnancy.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.